Altimmune, Inc. (ALT)
3.50
-0.10
(-2.78%)
USD |
NASDAQ |
Mar 13, 16:00
3.505
0.00 (0.00%)
After-Hours: 20:00
Altimmune Total Assets (Quarterly) : 279.93M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| CorMedix, Inc. | 877.63M |
| Amgen, Inc. | 90.59B |
| Viking Therapeutics, Inc. | 715.73M |
| Verastem, Inc. | 246.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.04M |
| Shareholders Equity (Quarterly) | 224.89M |
| Debt to Equity Ratio | 0.1587 |
| Current Ratio | 18.54 |
| Net Debt Paydown Yield | -1.69% |